Drug-labels.com

Bio-Montelukast: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx)
Strength:
10 mg, 4 mg, 5 mg

Patient Medication Information: uses, side effects, how to take - Bio-Montelukast

ABOUT THIS MEDICATION

What the medication is used for:

Asthma (for adults, adolescents and children 2 to 14 years old):

Your physician has prescribed Bio-MONTELUKAST to treat your asthma or your child’s asthma, including preventing your asthma symptoms during the day and night. When taken as prescribed, Bio-MONTELUKAST also prevents the narrowing of airways triggered by exercise.

Bio-MONTELUKAST can be used alone or together with other medications to help with the treatment and prevention of you or your child’s asthma. Your physician will decide which combination of medicines will work best for you or your child.

Seasonal Allergic Rhinitis (for adults and adolescents 15 years and older):

Your physician has prescribed Bio-MONTELUKAST to treat your seasonal allergies, including daytime and nighttime symptoms, including nasal congestion, runny nose, nasal itching, and sneezing; nasal congestion upon awakening; tearing, itchy, red, and puffy eyes.

What it does:

Bio-MONTELUKAST is a leukotriene receptor antagonist that blocks substances in your lungs called leukotrienes. Leukotrienes cause narrowing and swelling of airways in your lungs. Blocking leukotrienes improves asthma symptoms and helps prevent asthma attacks. Leukotrienes also can contribute to the development of allergy symptoms. Blocking leukotrienes improves seasonal allergy symptoms (also known as hay fever or seasonal allergic rhinitis).

When it should not be used:

Do not take Bio-MONTELUKAST if you or your child are allergic to any of its ingredients. See what the non-medicinal ingredients are.

What the medicinal ingredient is:

Montelukast sodium

What the non-medicinal ingredients are:

4 mg and 5 mg chewable tablet: aspartame, flavour cherry, hydroxypropylcellulose, magnesium stearate, mannitol, microcrystalline cellulose, croscarmellose sodium and red iron oxide.

Phenylketonurics: Bio-MONTELUKAST 4 mg and 5 mg chewable tablets contain 0.54 and 0.67 mg phenylalanine, respectively.

10 mg film-coated tablet: lactose monohydrate, microcrystalline cellulose, croscarmellose sodium, magnesium stearate, hydroxypropyl methylcellulose, hydroxypropyl cellulose, titanium dioxide, iron oxide yellow, carnauba wax and iron oxide red.

What dosage forms it comes in:

Bio-MONTELUKAST film-coated tablet: 10 mg Bio-MONTELUKAST chewable tablet : 4 mg and 5 mg.

WARNINGS AND PRECAUTIONS

Bio-MONTELUKAST is not for the treatment of acute asthma attacks. If an attack occurs, you or your child should follow the instructions your physician has given you for that situation.

Behavior and mood-related changes have been reported in patients taking Bio-MONTELUKAST. If you or your child experience these changes while taking Bio-MONTELUKAST (see “SERIOUS SIDE EFFECTS, HOW OFTEN THEY HAPPEN AND WHAT TO DO ABOUT THEM”), tell your physician.

BEFORE using Bio-MONTELUKAST, tell your physician if you or your child:

  • have phenylketonuria;
  • suffer from liver problems;
  • are using any other medicines;
  • have or have had any medical problems or allergies.

You should immediately inform your doctor if you or your child start to have any:

  • agitation, including aggressive behavior or

    hostility (such as temper tantrums in children),

  • suicidal thoughts and actions,
  • anxiousness, depression (sad mood),
  • disorientation (inability to know correct time, place

    or person), dream abnormalities, hallucinations (seeing or hearing things that are not there),

  • insomnia, irritability, restlessness, sleep walking,
  • tremors.
  • Disturbance in attention, memory problems,
  • stuttering

Use in pregnancy

Women who are pregnant or intend to become pregnant should consult their physician before taking Bio- MONTELUKAST.

Use in breast-feeding

It is not known if Bio-MONTELUKAST appears in breast milk. You s h o u l d c o n s u l t y o u r p h y s i c i a n b e f o r e t a k i n g Bio-MONTELUKAST if you are breast-feeding or intend to breast-feed.

Bio-MONTELUKAST is not expected to affect your ability to drive a car or operate machinery. However, individual responses to medication may vary. Certain side effects (such as dizziness and drowsiness) that have been reported very rarely with Bio-MONTELUKAST may affect some patients' ability to drive or operate machinery.

If your or your child’s asthma symptoms get worse, you should contact your physician immediately.

If your asthma is made worse by exercise, you should continue to use the medicines your physician has prescribed for you to use before exercise, unless your physician tells you otherwise. You should always have your inhaled rescue medicine for asthma attacks with you in case you need it.

If your asthma is made worse by acetylsalicylic acid (ASA) (e.g., Aspirin), you should continue to avoid ASA or other non-steroidal anti-inflammatory drugs.

INTERACTIONS WITH THIS MEDICATION

In general, Bio-MONTELUKAST does not interfere with other medicines that you may be taking. However, some medicines may affect how Bio- MONTELUKAST works, or Bio-MONTELUKAST may affect how your other medicines work. It is important to tell your physician about all drugs

that you are using or plan to use, including those obtained without a prescription.

PROPER USE OF THIS MEDICATION

Usual dose:

Asthma (for adults, adolescents and children 2 to 14 years old):

Take Bio-MONTELUKAST once a day in the evening with or without food, as your physician has prescribed.

Take Bio-MONTELUKAST daily for as long as your physician prescribes it in order to maintain control of your or your child’s asthma. Bio-MONTELUKAST can treat your or your child’s asthma only if you or your child continue to take it.

It is important that you or your child continue taking Bio-MONTELUKAST daily as prescribed by your physician, even when you or your child has no symptoms or if you or your child has an asthma attack.

If you are taking other medications along with Bio- MONTELUKAST your physician will instruct you how and when to take each medication. Your physician will increase or decrease the doses of these medications as needed.

Seasonal Allergic Rhinitis (for adults and adolescents 15 years and older):

Take Bio-MONTELUKAST once a day in the evening with or without food, as your physician has prescribed.

Remember that your physician has prescribed this medicine only for you or your child. Never give it to anyone else.

Follow up with your physician to ensure your continued health and safety.

Overdose:

In case of drug overdose, contact a health care practitioner, hospital emergency department or regional Poison Control Centre immediately, even if there are no symptoms.

Missed Dose:

Try to take Bio-MONTELUKAST as prescribed. However, if you miss a dose, just resume the usual schedule of one tablet once daily.

SIDE EFFECTS AND WHAT TO DO ABOUT THEM

Any medicine may have unintended or undesirable effects, so-called side effects. Bio-MONTELUKAST is generally well-tolerated.

The most common side effects reported were;

  • abdominal pain
  • headache
  • thirst
  • diarrhea
  • hyperactivity
  • asthma
  • scaly and itchy skin
  • rash

These were usually mild.

Additionally, the following have been reported:

  • upper respiratory tract infection (common cold)
  • feeling anxious, irritability, disturbance in

    attention,

  • memory problems, restlessness, sleep walking, sleep disorders including dream abnormalities and insomnia, uncontrolled muscle movements
  • dizziness, drowsiness, pins and needles/numbness
  • nose bleed
  • joint pain, muscle aches and muscle cramps tender red lumps under the skin, most commonly on your shins
  • weakness/tiredness, fatigue
  • swelling
  • fever
  • bedwetting in children

Tell your physician or pharmacist if you develop any of the above symptoms, any unusual symptom, or if any known symptom continues or worsens.

IMPORTANT: PLEASE READ
SERIOUS SIDE EFFECTS, HOW OFTEN THEY
HAPPEN AND WHAT TO DO ABOUT THEM
Symptoms / EffectsTalk with your physician or pharmacistStop taking drug and seek immediate emergency medical attention
Only if severeIn all cases
Raresymptoms of allergic reactions such as swelling of the face, lips, tongue, and/or throat (which may cause difficulty in breathing or swallowing), hives, rash, and itching√
Very Raresymptoms of liver problems: nausea, vomiting, fatigue, jaundice (yellowing of the skin and eyes), dark urine, flu-like symptoms, loss of appetite, and pain in your abdomen√
increased bleeding tendency, bruising, low blood platelet count√
severe skin reactions (erythema multiforme) that may occur without warning√
behavior and mood related changes [agitation including aggressive behavior or hostility (such as temper tantrums in children) or obsessive-compulsive symptoms]√
depression√
disorientation (inability to know correct time, place or person)√
suicidal thoughts and actions√
stuttering√
tremor√
hallucinations (seeing or hearing things that are not there)√
seizure (convulsions or fits)√
palpitations (heart skips a beat)√
SERIOUS SIDE EFFECTS, HOW OFTEN THEY
HAPPEN AND WHAT TO DO ABOUT THEM

Symptoms / Effects

eosinophilic

granulomatosis with polyangitis (EGPA), formerly kown as

Churg-Strauss syndrome: a flu-like illness, rash, pins and needles or numbness of arms or legs, joint pain and severe sinusitis

swelling (inflammation) of the lungs: breathing problems that continue to get worse

Talk with your

physician or pharmacist

Stop taking drug and seek

immediate emergency medical attention

Only if severeIn all cases
√
√

This is not a complete list of side effects. For any unexpected effects while taking Bio-MONTELUKAST, contact your physician or pharmacist.

HOW TO STORE IT

Store the 4 mg and 5 mg chewable tablets and the 10 mg film-coated tablets at room temperature (15°C-30°C). Protect from moisture and light. For blister package keep tablets in original package

Keep out of the reach and sight of children

Reporting Side Effects

You can report any suspected side effects associated with the use of
health products to Health Canada by:
  • Visiting the Web page on Adverse Reaction Reporting
(https://www.canada.ca/en/health-canada/services/drugs-
health-products/medeffect-canada/adverse-reaction-
reporting.html) for information on how to report online,
by mail or by fax; or
  • Calling toll-free at 1-866-234-2345.

NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

MORE INFORMATION

If you want more information about Bio-MONTELUKAST:

  • Talk to your healthcare professional
  • Find the full product monograph that is prepared for healthcare professionals and includes this Consumer Information by visiting Health Canada website (http://hc-sc.gc.ca/index-eng.php), or by contacting the manufacturer Biomed Pharma.

Biomed Pharma

info@biomed-pharma.ca

+1 (888) 731-6703

Last Revised: DEC 05, 2024

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02445735

Revision date stated in the text: December 5, 2024

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Bio-Montelukast

Rx or OTC
Prescription (Rx)?
DIN 02445735, 02553759, 02553767
Schedule(s) PRESCRIPTION
Active ingredient(s) Montelukast (montelukast sodium)
Dosage form(s) Tablet, Tablet (Chewable)
Route(s) of administration Oral
Drug class (WHO ATC)
  1. R Respiratory system drugs
    1. R03 Drugs for obstructive airway diseases
      1. R03D Other systemic drugs for obstructive airway diseases
        1. R03DC Leukotriene receptor antagonists for obstructive airway diseases
          1. R03DC03 Montelukast
Company BIOMED PHARMA
Strengths and forms
DIN Strength Dosage form(s) Current status
02445735 10 MG Tablet Marketed December 5, 2024
02553759 4 MG Tablet (Chewable) Approved December 5, 2024
02553767 5 MG Tablet (Chewable) Approved December 5, 2024

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.